NCT05578573 is a NA clinical trial of KARAHOC device in Ascites Hepatic, sponsored by Sang Gyune Kim.

Who is sponsoring NCT05578573?

NCT05578573 is sponsored by Sang Gyune Kim.

What drugs are being tested in NCT05578573?

Interventions in NCT05578573: KARAHOC device, Angiocatheter.

What condition does NCT05578573 study?

NCT05578573 studies Ascites Hepatic.

Is NCT05578573 still recruiting?

NCT05578573 is currently status unknown. Last updated 13 October 2022.

Last reviewed 2022-10-13 · How we verify

NCT05578573

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis

Status unknown NA Last updated 13 October 2022

What this trial tests

NA trial testing KARAHOC device in Ascites Hepatic in 80 participants. Status unknown.

Timeline

17 January 2022

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Sang Gyune Kim
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	17 January 2022
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across South Korea

Drugs / interventions tested

KARAHOC device
Angiocatheter

Conditions studied

Ascites Hepatic — all drugs for Ascites Hepatic →

Sponsor

Sang Gyune Kim — full company profile →

Who can join

19 and older, any sex, with Ascites Hepatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of success rate and complication between conventional angiocatheter versus new anchoring device (KARAHOC) used for paracentesis in cirrhotic patients with ascites.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ascites Hepatic

Currently open trials in the same condition.

NCT06576934 — Early TIPS in Patients With Liver Cirrhosis and Ascites · NA · recruiting
NCT06669806 — Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension · NA · recruiting
NCT07349654 — Underdilated-stent Technique Improves Post-TIPS Encephalopathy · NA · recruiting
NCT06224023 — Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure · recruiting
NCT05999773 — SGLT-2 Inhibitors in the Treatment of Ascites · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05578573 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sang Gyune Kim
Last refreshed: 13 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05578573.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing